Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04948385
Other study ID # B7007201938885
Secondary ID
Status Completed
Phase Phase 4
First received
Last updated
Start date February 6, 2019
Est. completion date May 6, 2019

Study information

Verified date June 2021
Source University of Liege
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Many drugs used during anesthesia can reduce alertness and therefore present potential risks when driving a vehicle (risk of accident). Some scientific societies recommend not driving for 12 to 24 hours after sedation or general anesthesia. However, there are conflicting data in the literature showing that general anesthesia in healthy volunteers does not impair driving ability as early as 2 hours after the end of anesthesia. This need not to drive requires the outpatient to have an escort. Unfortunately, some patients find it difficult to benefit from an adult escort, which can lead to last minute cancellations, absences or the need for a classic overnight hospital stay. The main objective of the study is to compare with a simulator the driving performances of patients who have benefited from deep sedation for an outpatient endoscopic digestive procedure when they have met the discharge criteria to the performances of their escorts in order to determine if the conditions are as safe to let them drive home.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 6, 2019
Est. primary completion date May 6, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Presence of a driver license Exclusion Criteria: - Unavailabilty of the escort for the duration of the examination - No driving for the past 5 years - Refusal of participation

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Propofol
deep sedation with propofol +/- adjuvants such as midazolam, sufentanil, lidocaine and/or dehydrobenperidol
Procedure:
No sedation
No sedation

Locations

Country Name City State
Belgium Centre hospitalier universitaire de Liege Liège

Sponsors (1)

Lead Sponsor Collaborator
University of Liege

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Travel time until the end of the driving test, an average of 1 hour.
Primary Number of collisions until the end of the driving test, an average of 1 hour.
Primary Number of collisions with a pedestrian until the end of the driving test, an average of 1 hour.
Primary Number of times over the speed limit until the end of the driving test, an average of 1 hour.
Primary Percentage of speeding time until the end of the driving test, an average of 1 hour.
Primary Percentage of speeding distance until the end of the driving test, an average of 1 hour.
Primary Number of speeding ticket until the end of the driving test, an average of 1 hour.
Primary Number of crossings of the median line until the end of the driving test, an average of 1 hour.
Primary Number of passages on the shoulder until the end of the driving test, an average of 1 hour.
Primary Percentage of time out of traffic lane until the end of the driving test, an average of 1 hour.
Primary Percentage of distance out of traffic lane until the end of the driving test, an average of 1 hour.
Primary Number of broken stops until the end of the driving test, an average of 1 hour.
Primary Number of stops at traffic lights until the end of the driving test, an average of 1 hour.
Primary Number of traffic light ticket until the end of the driving test, an average of 1 hour.
Secondary Karolinska Sleepiness Scale (KSS) 9-points scale : 1 (extremely alert) to 9 (very sleepy) Within 30 minutes before driving test with simulator
Secondary Karolinska Sleepiness Scale (KSS) 9-points scale : 1 (extremely alert) to 9 (very sleepy) Within 10 minutes after driving test with simulator
Secondary Beck II Depression inventory score (BDI-II) 21 items - 0 to 3 points by item - 0 (minimal) to 63 (severe depression) Within 30 minutes before driving test with simulator
Secondary STOP-Bang questionnaire (Snoring, Tired, Observed, Pressure, Body Mass index > 35, Age, Neck size, Gender) 0 to 8 points (0 = low risk to 8 = high risk of sleep apnea) Within 30 minutes before driving test with simulator
See also
  Status Clinical Trial Phase
Recruiting NCT06059677 - Cannabis Consumption and Driving Impairment Assessment on a Closed Course Phase 2
Enrolling by invitation NCT05537116 - Evaluation of an Interactive Mobile Phone-Based Brief Intervention to Reduce Substance-Impaired Driving N/A
Completed NCT03169855 - Validation of Mesopic and Photopic Contrast Vision Tests With Respect to Nighttime Driving Ability
Recruiting NCT06111989 - Fitness to Drive Among Stroke Patients
Completed NCT04587609 - Reducing Cell Phone Use While Driving Among High Risk UBI Auto Policy Holders N/A
Completed NCT03656029 - Dose-response of Cannabis and Driving Phase 2
Completed NCT04330196 - Effect of Postprandial Hyperinsulinaemic Hypoglycaemia on Driving Performance. N/A
Completed NCT03353922 - Driving Simulation to Assess Non-Sedative Effects of Tolperisone Phase 1
Completed NCT03335735 - Smartphone-paired Breathalyzers and Loss- and Gain-framed Texts for Reducing Drinking and Driving N/A
Not yet recruiting NCT05703360 - Effectiveness of AV-stimulation in Immersive VR to Improve Visual Perception and Driving Performance N/A
Active, not recruiting NCT03581058 - Neural Correlates of Driving and Cannabis Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Completed NCT04648735 - Driving Evaluation and Fitness for Persons With Cognitive Impairments N/A
Completed NCT03195608 - Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease N/A